Synthesis of Imidazo[4,5-b]quinoxaline Ribonucleosides as Linear Dimensional Analogs of Antiviral Polyhalogenated Benzimidazole Ribonucleosides

Journal of the Chinese Chemical Society

Volumn 45, Issue 4, 1998, Pages 465-474

  Zhu, Zhijian ^a   Saluja, Sunita ^b   Drach, John C ^c   Townsend, Leroy B ^c  

^a PFIZER INC   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c NONE

Author keywords

Antivirals; Benzimidazole; Herpes; Imidazo 4,5 b quinoxaline; Nucleosides; Polyhalogenated

Indexed keywords

EID: 0042075457     PISSN: 00094536     EISSN: None     Source Type: Journal    
DOI: 10.1002/jccs.199800071     Document Type: Article

References (33)

1. Alford, C. A.; Britt, W. J. Cytomegalovirus. in The Human Herpesviruses; Roizman, B., Whitley, R. J., Lopez, C., Eds., Raven Press: New York, 1993; pp 7-255.
2. Alford, C. A.; Stagno, S.; Pass, R. F.; Britt, W. J. Congenital and perinatal cytomegalovirus infections. Rev. Infect. Dis. 1990, 12, S745-S753.
3. Wingard, J. R.; Piantadosi, S.; Burns, W. H.; Zahurak, M. L.; Santos, G. W.; Saral, R. Cytomegalovirus infections in bone marrow transplant recipients given intensive cytoreductive therapy. Rev. Infect. Dis. 1990, 12, S793-S804.
4. Rubin, R. H. Impact of cytomegalovirus infection on organ transplant recipients. Rev. Infect. Dis. 1990, 12, S754-S766.
5. Gallant, J. E.; Moore, R. D.; Richman, D. D.; Keruly, J.; Chaisson, R. E. et al. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J. Infect. Dis. 1992, 166, 1223-1227.
6. (a) Faulds, D.; Heel, R. C. Ganciclovir. A Review of its Antiviral Activity, Pharmacokinetic Properties and Therapeutic Efficacy in Cytomegalovirus Infections. Drugs 1990, 39, 597-638.
7. (b) Chrisp, P.; Clissold, S. P. Foscamet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs 1991, 41, 104-129.
8. Field, A. K.; Biron, K. K. "The End of Innocence" Revisited: Resistance of Herpesviruses to Antiviral Drugs. Clin. Microbiol. Rev. 1994, 7, 1-13.
9. (a) Millar, A. B.; Miller, R. F.; Patou, G.; Mindel, A.; Marsh, R.; Semple, S. J. Treatment of cytomegalovirus retinitis with zidovudine and ganciclovir in patients with AIDS: outcome and toxicity. Genitourin. Med. 1990, 66, 156-158.
10. (a) Townsend, L. B.; Drach, J. C. and coworkers presented at the Fifth Internat. Conf. Antiviral Res., Vancouver, BC, 1992, Abstracts 12, 105, 107, 108, 110.
11. (b) Townsend, L. B.; Devivar, R. V.; Turk, S. R.; Nassiri, M. R.; Drach, J. C. Design, Synthesis and Antiviral Activity of Certain 2,5,6-trihalo-1-(β-D-ribofuranosyl)benzimidazoles. J. Med. Chem. 1995, 38, 4098-4105.
12. Devivar, R. V.; Kawashima, E.; Revankar, G. R.; Breitenbach, J. M.; Kreske, E. D.; Drach, J. C.; Townsend, L. B. Benzimidazole ribonucleosides: Design, synthesis and antiviral evaluation of certain 2-(alkylthio)- and 2-(benzylthio)-5,6-dichloro-1-(β-D-ribofuranosyl)benzimidazoles. J. Med. Chem. 1994, 37, 2942-2949.
13. Nassiri, M. R.; Emerson, S. G.; Devivar, R. V.; Townsend, L. B.; Drach, J. C.; Taichman, R. S. Comparison of benzimidazole nucleosides and ganciclovir on the in vitro proliferation and colony formation of human bone marrow progenitor cells. Brit. J. Haematol. 1996, 93, 273-279.
14. Tamm, I.; Folkers, K.; Shunk, C. H.; Horstall, F. L. Inhibition of influenza virus multiplication by N-glycosides of benzimidazoles. J Exp. Med. 1954, 99, 227-250.
15. (a) Underwood, M. R.; Biron, K. K.; Hemphill, M. L.; Miller, T. J.; Stanat, S. C.; Dornsife, R. E.; Drach, J. C.; Townsend, L. B.; Edwards, C. A.; Harvey, R. J. High Molecular Weight HCMV DNA Does Not Properly Mature in the Presence of 2-Bromo-5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (BDCRB), Presented at the Herpesvirus Workshop, Pittsgurgh, PA, July 1993.
16. (b) Underwood, M. R.; Stanat, S. C.; Drach, J. C.; Harvey, R. J.; Biron, K. K. Inhibition of HCMV DNA processing by a new class of anti-HCMV compounds is mediated through the UL89 gene product. Presented at the Herpesvirus Workshop, Vancouver, BC, August 1994.
17. Biron, K. K.; Davis, M. G.; Stanat, S. C.; Wallon, L. M.; Smith, A.; Koszalka, G. W.; Drach, J. C.; Townsend, F. B.; Harvey, R. J. Antiviral activity and mechanism of action of 1263W94, A benzimidazole riboside inhibitor of human cytomegalovirus. 36th Interscience Conf. Antimicrob. Agents Chemother., New Orleans, LA; September 1996.
18. Zhu, Z.; Lippa, B.; Drach, J. C.; Townsend, L. B. Synthesis of imidazo[4,5-b]quinoline nucleosides as linear tricyclic analogs of TCRB and BDCRB. 210th Amer. Chem. Soc. Div. Med. Chem. National Meeting, Chicago, IL, August 1995.
19. Cheeseman, G. W. H. Quinoxalines and Related Compounds. Part VI. Substitution of 2,3-Dihydroxyquinoxaline and its 1,4-Dimethylderivative. J. Chem. Soc. 1962, 1170-1176.
20. Schipper, E.; Day, A. R. Studies in Imidazoles. I. Imidazo(b)quinoxalines. J. Am. Chem. Soc. 1951, 73, 5672-5675.
21. Cheeseman, G. N. H.; Cookson, R. F. Condensed Pyrazines in the Chemistry of Heterocyclic Compounds, Weissberger, A.; Taylor, E. C. Eds. John Wiley & Sons, Inc., New York, 1979, pp 663-671.
22. Vorbruggen Method: (a) Vorbruggen, H.; Krolikiewicz, K.; Bennua, B. Nucleoside Synthesis XXII. Nucleoside Synthesis with Trimethylsilyl Triflate and Perchlorate as Catalysts. Chem. Ber. 1981, 114, 1234-1255.
23. (b) Vorbruggen, H.; Bennua, B. Nucleoside Synthesis XXV. A New Simplified Nucleoside Synthesis. Chem. Ber. 1981, 114, 1279-1286.
24. (c) Dudycz, L.; Wright, G. E. A Simple One-pot Method for 6-Oxopurine Ribonucleoside Synthesis: Control and Mechanism of Isomer Distribution. Nucleosides Nucleotides 1984, 3, 33-44.
25. 1H Constants for Assigning the Site of Glycosylation of Nitrogen Heterocycles. J. Chem. Soc. Perkin. II, 1980, 1586-1591.
26. (b) Kalinowski, H.-O.; Gerger, S.; Braun. S. Carbon-13 Spectroscopy John Wiley & Son Inc. 1986, pp 57-59.
27. (c) Bock, K.; Pederson, C. Assignment of Long-range Carbonproton Couplings through Selective Proton Decoupling. J. Magn. Reson. 1977, 5, 227-230.
28. Divakar, K. J.; Reese, C. 4-(1,2,4-Triazol-1-yl)-and 4-(3-nitro-1,2,4-triazol-1-yl)-1-(β-D-2.3,5-tri-O-acetylarabinoturanosyl) pyrimidin-2(1H)-ones. Valuable Intermediates in the Synthesis of Derivatives of 1-(β-D-Arabinofuranosyl)cytosine (AraC). J. Chem. Soc. Perkin Trans., I, 1982, 1171-1176.
29. Robins, R. K. A New Synthesis of Chloropurine Ribonucleosides. J. Am. Chem. Soc. 1960, 82, 2654-2655.
30. Turk, S. R.; Shipman, C., Jr.; Nassiri, M. R.; Genzingler, G.; Krawczyk, S. H.; Townsend, L. B., Drach, J. C. Pyrrolo[2,3-d]pyrimidine Nucleosides as Inhibitors of Human Cytomegalovirus. Antimicrob. Agents Chemother. 1987, 31, 544-550.
31. Prichard, M. N.; Turk, S. R.; Coleman, L. A.; Engelhardt, S. L.; Shipman, C., Jr.; Drach, J. C. A Microtiter Virus Yield Reduction Assay for The Evaluation of Antiviral Compounds Against Human Cytomegalovirus and Herpes Simplex Virus. J. Virol. Methods, 1990, 28, 101-106.
32. Prichard, M. N.; Shipman, C., Jr. A Three-Dimensional Model To Analyze Drug-Drug Interactions. Antiviral Res. 1990, 14, 181-206.
33. Prichard, M. N.; Prichard, L. E.; Baguley, W. A.; Nassiri, M. R.; Shipman, C., Jr. Three-Dimensional Analysis of the Synergistic Cytotoxicity of Ganciclovir and Zidovudine. Antimicrob. Agents Chemother. 1991, 35, 1060-1065.